Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taliglucerase Alfa Extension Study in Pediatric Gaucher Disease
NCT01411228Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2011
- Primary completion
- Jul 2014
- Modality
- Replacement Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of taliglucerase alfa in Gaucher disease (GD), sponsored by Pfizer. Started Sep 2011; status: completed.
02
Drugs
taliglucerase alfa
03
Conditions
Gaucher disease (GD)
Beyond the preview
Go deeper on NCT01411228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01411228.